NIH-funded research NIH-funded research

Investigating how bacterial vaginosis affects HIV risk through immune cells

Official title: The Role of the Macrophage in Bacterial Vaginosis Mediated HIV Risk

Funded at University of Florida · NIH-10918470 · Data updated 2026-11-12

This study is looking at how bacterial vaginosis (BV) might affect the immune system and increase the risk of HIV in women, by checking the vaginal fluid of women with and without BV to see how different bacteria influence immune cells.

Quick facts

Grant typeNIH-funded research
Study typeNIH-funded research
Funding institutionUniversity of Florida
NIH-funded
Lab location1 site (Gainesville, United States)
Project startSeptember 1, 2024
Project endJuly 31, 2029
Funding year2024
Award (this year)$533,750
NIH project number1DP1HD115449-01
Project IDNIH-10918470 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research are women of reproductive age who have been diagnosed with bacterial vaginosis or are otherwise healthy.

Less likely to help

Patients who do not have bacterial vaginosis or are not at risk for HIV may not benefit from this research.

What this research studies

This research explores the connection between bacterial vaginosis (BV) and increased risk of HIV infection by examining how BV influences immune cells called macrophages. The study will analyze vaginal fluid samples from women with and without BV to understand how different microbial compositions affect macrophage behavior. By using advanced techniques like proteomics and machine learning, researchers aim to identify specific microbial factors that may lead to a higher susceptibility to HIV. This could provide insights into potential prevention strategies for women at risk.

Why it matters

Potential benefit: If successful, this research could lead to new strategies for preventing HIV in women affected by bacterial vaginosis.

How similar studies have gone: Previous research has shown that understanding the microbiome's role in immune response can lead to significant advancements in HIV prevention strategies.

Where this research is happening

  • University of Florida
    Gainesville, United States
    Active

Researchers

  • Principal investigator: Parker, Ivana — University of Florida
  • Study coordinator: Parker, Ivana

Related research

Other NIH-funded projects on the same topics.

  • Mitochondrial pores and muscle loss in cancer cachexia

    A small US-based study will explore how changes in mitochondria contribute to muscle wasting in people with cancer cachexia and how this may be slowed.

    NIH research University of Florida · Gainesville, United States · NIH-11636110

  • Photobiomodulation for jaw pain from TMD

    A clinician-scientist at the University of Florida is testing a light-based therapy to help adults with temporomandibular disorder pain feel better and jaw function improve.

    NIH research University of Florida · Gainesville, United States · NIH-11635590

  • How the brain controls swallowing and airway protection

    A research team at the University of Florida is studying how brain networks control swallowing to reduce risk of choking and lung infections in people with neuromuscular diseases.

    NIH research University of Florida · Gainesville, United States · NIH-11630949

  • Donor-driven 3D organoid platform to study pancreatic cancer drug response

    A pilot project to create patient-derived, 3D organoid models of pancreatic cancer to measure how tumors from different people respond to chemotherapy.

    NIH research University of Florida · Gainesville, United States · NIH-11625599

  • RAAS inhibitors and pancreatic cancer risk in diverse adults

    A Florida-based study will look at whether commonly used blood pressure medicines (RAAS inhibitors) are linked to new cases of pancreatic cancer, especially among Black and Hispanic adults.

    NIH research University of Florida · Gainesville, United States · NIH-11625597

  • Pilot project exploring new cancer drugs for pancreatic cancer in African American patients

    A small, early-stage project tests new drug-derived compounds to treat pancreatic cancer, focusing on African American patients who are disproportionately affected.

    NIH research University of Florida · Gainesville, United States · NIH-11625594

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.